ADHD is treated with two main classes of medication: stimulants and non-stimulants. Stimulants are the first-line treatment for most people and work effectively in roughly 70 to 80 percent of cases. They come in two families, methylphenidate-based and amphetamine-based, each available in multiple formulations that differ in how long they last and how they’re taken.
Stimulant Medications
Stimulants increase the availability of two chemical messengers, dopamine and norepinephrine, in the front part of the brain responsible for attention, planning, and impulse control. In simple terms, they strengthen the signals your brain needs to focus while quieting the background noise that makes concentration difficult. This is why stimulants improve all three core ADHD symptoms: inattention, hyperactivity, and impulsivity.
The two stimulant families are:
- Methylphenidate-based: Ritalin, Concerta, Focalin, Metadate, Daytrana (a skin patch applied to the hip), and several generic versions.
- Amphetamine-based: Adderall, Vyvanse (lisdexamfetamine), Dexedrine, and their generics. The FDA also recently approved an oral liquid form of lisdexamfetamine (Arynta) for people who have difficulty swallowing pills.
If one family doesn’t work well for you or causes too many side effects, the other often does. The two families act on the same chemical messengers but through slightly different mechanisms, which is why switching between them is a common and effective strategy.
Short-Acting vs. Long-Acting Formulations
The biggest practical difference between stimulant medications is how long they last. Short-acting (immediate-release) versions typically wear off in about four hours, meaning you may need two or three doses throughout the day. Long-acting (extended-release) versions are designed to cover most of the waking day with a single morning dose.
Here’s how the major long-acting options compare in duration:
- Vyvanse: 10 to 12 hours
- Concerta: 8 to 13 hours
- Adderall XR: 8 to 10 hours
- Ritalin LA: about 8 hours
- Daytrana (patch): about 9 hours
- Dexedrine Spansule: about 8 hours
Many people use a long-acting medication as their daily base and add a small short-acting dose in the late afternoon if coverage wears off before the evening. Your prescriber will typically start at a low dose and adjust upward weekly until symptoms improve without bothersome side effects. For adults starting on Adderall XR, for example, the typical starting dose is 20 mg once daily in the morning.
Common Side Effects of Stimulants
Decreased appetite is the most common side effect, affecting roughly 80 percent of people who take stimulant medications. For many, this is most noticeable during the hours the medication is active and eases by dinnertime. Eating a solid breakfast before the medication kicks in and having a larger evening meal can help offset the effect.
Difficulty falling or staying asleep is the other frequently reported issue. Taking the medication earlier in the day, choosing a formulation that wears off sooner, or adjusting the dose often resolves this. Stimulants can also raise heart rate slightly, though the increase is usually minor. If you have a history of heart problems, that’s important information to share before starting treatment.
Some people also experience headaches, dry mouth, or mild increases in anxiety, particularly during the first few weeks. These tend to diminish as the body adjusts. Weight loss from appetite suppression is worth monitoring over time, especially in children and adolescents who are still growing.
Non-Stimulant Medications
Non-stimulants are used when stimulants cause unacceptable side effects, when someone has a condition that makes stimulants risky (like certain heart conditions or a history of substance misuse), or when stimulants alone don’t fully manage symptoms. They generally take longer to reach full effect, often two to six weeks, compared to the near-immediate response most people get from stimulants.
The main FDA-approved non-stimulant options include:
- Atomoxetine (Strattera): Works by increasing norepinephrine activity in the brain. It provides 24-hour coverage and has no abuse potential, which makes it a good fit for people with co-occurring substance use concerns.
- Viloxazine (Qelbree): A newer option that also targets norepinephrine, approved for both children and adults.
- Guanfacine extended-release (Intuniv): Originally developed for blood pressure, it helps with impulsivity and hyperactivity. Often used alongside a stimulant rather than on its own.
- Clonidine extended-release (Kapvay): Similar to guanfacine in its mechanism. Can also help with sleep difficulties related to ADHD or stimulant use.
Non-stimulants generally produce milder side effects than stimulants. Drowsiness and fatigue are the most common complaints, particularly with guanfacine and clonidine. Atomoxetine can cause nausea and, less commonly, mood changes in the first weeks of treatment.
Off-Label Options
When standard medications don’t work well enough, some prescribers turn to medications used off-label, meaning they’re FDA-approved for other conditions but have evidence supporting their use in ADHD. Bupropion, an antidepressant that affects dopamine and norepinephrine, is one of the more commonly used off-label choices, particularly when ADHD co-occurs with depression.
Modafinil, a wakefulness-promoting drug approved for sleep disorders, has also shown promise. A meta-analysis of randomized controlled trials found it improved ADHD symptoms compared to placebo in children and adolescents. Its side effect profile differs from traditional stimulants: it didn’t cause clinically significant increases in heart rate or blood pressure, though it did increase rates of appetite loss and insomnia. It’s not FDA-approved for ADHD, so access can be more complicated and insurance coverage less predictable.
How Medications Are Chosen
There’s no blood test or brain scan that predicts which ADHD medication will work best for a given person. The process is largely trial and observation. Most prescribers start with a stimulant because stimulants have the strongest evidence base and the fastest onset. If the first medication tried doesn’t work, that doesn’t mean medication won’t help. It often takes two or three trials to find the right drug and dose.
Several practical factors shape the decision. A child who can’t swallow pills might start with a liquid, chewable tablet, or the Daytrana skin patch. A college student who needs coverage for long study sessions might benefit from Vyvanse’s 10-to-12-hour window. An adult with co-occurring anxiety might do better with a non-stimulant that won’t amplify jittery feelings. Someone whose symptoms are mainly hyperactivity and impulsivity rather than inattention may respond well to guanfacine added alongside a lower-dose stimulant.
Medication is also more effective when combined with behavioral strategies, organizational tools, and, for many people, therapy that targets the habits and thought patterns ADHD creates over time. The medication handles the neurochemistry; the skills handle the life structure.